REMS Removed for Rosiglitazone Diabetes Drugs


REMS deemed unnecessary to ensure drug benefits outweigh risks.

The FDA is eliminating the Risk Evaluation and Mitigation Strategy (REMS) for type 2 diabetes medications containing rosiglitazone.

The agency reached this decision after monitoring the effects of rosiglitazone medications, which are approved as generics and brand names Avandia, Avandamet, Avandaryl. It ultimately deemed the REMS unnecessary to ensure that the drugs’ benefits outweigh their risks.

In 2013, the FDA determined that there was no increased risk of heart attack in patients treated with rosiglitazone compared with those treated with metformin and sulfonylurea. Subsequently, the FDA asked manufactures to remove prescribing and dispensing restrictions for medications containing rosiglitazone.

The agency did, however, require drug manufacturers to provide educational training to health care professionals to keep them informed on the latest findings regarding the potential link between rosiglitazone and heart disease risk.

In addition to contacting their health care professionals, patients who have experienced adverse reactions after taking these products should report them to the FDA’s MedWatch Adverse Event Reporting program.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 -
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
Capsules medicine and white medicine bottles on table | Image Credit: Satawat -
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn -
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg -
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl -
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka -
Bottle and scattered pills on color background, top view | Image Credit: New Africa -
© 2024 MJH Life Sciences

All rights reserved.